
NASDAQ:TLRY
This summary was created by AI, based on 3 opinions in the last 12 months.
Tilray Inc. (TLRY-Q) has recently faced challenges in revenue performance, with reports indicating significant declines. In one review, Tilray reported a revenue of $288 million, reflecting a 6.6% decrease from the previous quarter, while gross profit decreased by 14.9%, demonstrating efficiency concerns in production and sales. Another report highlights an even steeper fall, with revenue reported at $210 million, a notable 32% decline from the previous quarter and gross profit dropping by 38.1%. Despite these declines, there is growing social media attention, with mentions up 28.2% and 24.9% in the last 24 hours respectively. Experts suggest that investors should consider reassessing their positions and highlight that U.S. cannabis stocks may present better opportunities than Canadian counterparts like Tilray.
A lot of $$ was made, but now investors have come to realize marijuana is just a commodity. The company bears all the costs, but it has the federal/provincial government as a partner that shares equally in all the upside, but none of the down. Even advertising is restricted.
For a consumer stock, he holds Unilever.
So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.
Tilray Inc. is a American stock, trading under the symbol TLRY (previously TLRY-Q on Stockchase) on the NASDAQ (TLRY). It is usually referred to as NASDAQ:TLRY or TLRY
In the last year, 1 stock analyst published opinions about TLRY (previously TLRY-Q on Stockchase). 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Tilray Inc..
Tilray Inc. was recommended as a Top Pick by Jim Cramer - Mad Money on 2022-09-30. Read the latest stock experts ratings for Tilray Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Tilray Inc. in the last year. It is a trending stock that is worth watching.
On 2026-05-26, Tilray Inc. (TLRY) stock closed at a price of $5.45.
Even with talk of rescheduling cannabis, US names offer significantly more upside than Canadian names. Look to the US if you want to take on this risk. If you own this one, use it as a tax loss.